Does Huntington's disease qualify for NDIS?

Yes. Huntington's disease (HD) qualifies for NDIS as a progressive neurological condition. For people who develop HD symptoms before age 65, NDIS is the primary funding pathway. HD is a genetic condition (autosomal dominant, caused by a CAG repeat expansion in the HTT gene) and causes progressive neurological disability affecting movement, cognition, behaviour, and swallowing. NDIS plans for HD require regular review as the progressive nature of the condition means support needs increase substantially across the disease course. For people who develop symptoms at 65 or over, the aged care system (Support at Home program via My Aged Care) is the appropriate pathway.

What are the main stages of Huntington's disease and how do support needs change?

HD progresses through broadly recognisable stages, though the rate and pattern of progression varies between individuals. Early stage: motor symptoms (chorea, balance difficulties), early cognitive changes (executive function, attention), and mood and personality changes; the person is typically still independent in most daily tasks but may need assistance with specific activities. Middle stage: significant motor, cognitive, and behavioural difficulties; daily support with personal care, domestic tasks, and community access is needed; communication and swallowing changes become apparent. Late stage: severe functional impairment across all domains; the person requires full-time personal care; swallowing is significantly affected; communication is severely limited; palliative care becomes the primary focus. Support needs increase substantially at each transition.

What behaviour changes occur in Huntington's disease and how should support respond?

Neuropsychiatric features are among the most significant and most difficult aspects of HD for families. Common behaviour changes include depression (affecting up to 50% of people with HD), irritability and aggression, anxiety, obsessive-compulsive behaviours, apathy (which is distinct from depression and can be very impairing), disinhibition, and in some cases psychosis. These are neurological features of HD, not character changes or deliberate behaviour. They require: accurate assessment (distinguishing depression from apathy, distinguishing HD-related behaviour from pre-existing personality); appropriate treatment (medication for depression, anxiety, psychosis, and chorea managed by the neurologist or psychiatrist); and consistent, calm, structured support worker approaches that do not escalate or respond punitively to behaviour that is neurologically driven.

When does swallowing become a concern in Huntington's disease?

Swallowing difficulties (dysphagia) become a clinical priority in the middle and late stages of HD. Chorea affecting the mouth, tongue, and throat muscles disrupts the coordination of swallowing. This significantly increases the risk of aspiration (food or liquid entering the airway), which is a leading cause of aspiration pneumonia and death in HD. A speech pathologist conducts swallowing assessments and recommends dietary modifications (texture-modified food and thickened fluids using the IDDSI framework). Support workers and family carers must be trained in: recognising signs of swallowing difficulty; safe mealtime positioning; the recommended diet textures and fluid consistencies; and emergency response to choking.

What role does a support coordinator play in Huntington's disease?

Support coordination in HD is particularly complex because the condition is progressive, the person's decision-making capacity diminishes over time, the provider team is large, and advance care planning must be initiated while the person still has capacity to participate. A support coordinator with neurodegenerative disease experience: manages the NDIS plan across multiple transitions; coordinates between neurologist, speech pathologist, OT, physiotherapist, psychologist, and daily support workers; facilitates advance care planning conversations with the person and family before capacity is affected; manages provider handover when new providers are needed; and coordinates palliative care integration in late-stage HD.

What does palliative care in Huntington's disease involve?

Palliative care for HD focuses on quality of life, comfort, and the management of distressing symptoms across all stages of the disease, not just the end of life. Earlier palliative care involvement in HD improves outcomes and reduces unnecessary interventions in late stage. Palliative care in HD addresses: pain management (HD can involve pain that may not be communicated effectively in late stage); symptoms such as chorea, dystonia, and rigidity; nutritional support decisions (PEG tube placement is a significant decision in HD requiring advance care planning); respiratory management; and family and carer support. Australia's neurodegenerative care advisory groups, including the NDIA's Neurodegenerative, Palliative Care and Rare Diseases Advisory Group established in 2024, are working to improve integrated neuro-palliative care for HD.

What is the NDIS doing for people with Huntington's disease?

Approximately 1,100 NDIS participants had HD as their primary disability as of 2025. The NDIS has recognised the particular challenges of neurodegenerative conditions under current planning frameworks and has established the Neurodegenerative, Palliative Care and Rare Diseases Advisory Group to advise on improving support for this group. Current NDIS planning frameworks are better suited to stable conditions than progressive ones; advocacy from Huntington's Australia and the HD community is ongoing to ensure plans adequately reflect the progressive nature of HD and that transitions between stages are managed proactively rather than reactively.

What does Huntington's Australia provide for families?

Huntington's Australia is the national organisation for people with HD and their families. They provide: information about HD and current research and treatment developments; peer support connecting families with others with lived experience of HD; a helpline staffed by specialist HD social workers and support advisors; advocacy for improved access to HD-specific services; information on NDIS navigation for HD families; resources for family members at risk (genetic testing, family planning considerations); and connection to the international HD community. Huntington's Australia's specialist advisors understand the unique features of the HD care journey and can assist with support planning.

Huntington's Disease Care Journey: Transition Points and Provider Handover Checklist

Key Points

HD qualifies for NDIS for people under 65 with symptoms; plans require regular review given the progressive nature of the condition; support needs increase substantially at each stage transition
Neuropsychiatric features (depression, irritability, apathy, disinhibition) are neurological features of HD, not character changes; accurate assessment and appropriate treatment alongside consistent, calm support are the response
Swallowing assessment by a speech pathologist is a clinical priority in middle and late stage HD; aspiration pneumonia is a leading cause of death; all support workers must be trained in safe mealtime practice
Palliative care should be integrated earlier in HD than in many other conditions; advance care planning must begin while the person has capacity to participate in decisions
Support coordination in HD requires proactive planning for transitions, advance care planning facilitation, and coordination across a large multidisciplinary team
Huntington’s Australia’s specialist social workers and support advisors provide expert guidance for HD families navigating NDIS, care transitions, and genetic implications

The Huntington’s Disease Care Journey

Huntington’s disease is an inherited neurodegenerative condition caused by a CAG repeat expansion in the HTT gene on chromosome 4. It causes progressive deterioration in motor function, cognition, and behaviour, typically beginning in the third to fifth decade of life, though juvenile onset (under 20) and late onset (over 60) occur.

HD follows an autosomal dominant inheritance pattern: each child of a person with HD has a 50% chance of inheriting the gene mutation. This means HD is not only a condition affecting the individual; it affects the entire family system, with genetic testing decisions, family planning implications, and the experience of watching a parent deteriorate all part of the HD family journey.

In Australia, it is estimated that approximately 2,000 people live with symptomatic HD, with a similar number having the gene mutation without yet showing symptoms. Huntington’s Australia estimates one Australian family in every 10,000 is directly affected by HD.

The HD care journey is long, typically spanning 10 to 25 years from symptom onset to death. This guide covers the transition points, the provider handover process, and the key clinical and support considerations at each stage.

NDIS Access for Huntington’s Disease

HD qualifies for NDIS as a progressive neurological condition. For people who develop symptoms before 65, NDIS is the primary support funding pathway.

Access documentation needed:

Neurologist report confirming HD diagnosis (genetic testing result showing CAG repeat expansion in the pathological range)
Functional evidence documenting daily living impacts at the time of application

What NDIS funds:

Core: Personal care, daily living support, community access, SIL in advanced stages
Capacity Building: Speech pathology, OT, physiotherapy, psychology, behaviour support, support coordination
Capital: Assistive technology, home modifications, communication technology

Planning considerations specific to HD:

Plans must be built with forward visibility; a plan that meets current needs will be insufficient within 12 to 18 months without review
Regular plan reviews (every 12 months or at significant transitions) are essential
Anticipatory planning (funding for equipment and supports before they become urgent) prevents gaps in care

The Transition Points

Early Stage: Diagnosis to Significant Functional Impact

The early stage of HD involves subtle changes that may predate formal diagnosis or occur in the period immediately after diagnosis. Key tasks:

Establishing the provider team:

Neurologist (primary specialist; motor symptoms, medication management)
Neuropsychologist (baseline cognitive and behavioural assessment; monitoring)
Speech pathologist (baseline communication and swallowing assessment)
Physiotherapist (balance, falls prevention, exercise)
OT (home and functional assessment; anticipatory equipment planning)
Psychologist (mental health, adjustment, family support)

Advance care planning (begin now, while capacity is intact):

Appointing an Enduring Power of Attorney (medical and financial)
Completing an Advance Care Directive documenting wishes about treatment decisions
Discussing key decision points: ventilation, PEG tube placement, resuscitation status, preferred place of care in late stage

Genetic implications for family:

Genetic counselling for adult children at risk
Genetic testing support (the decision whether to test is deeply personal and requires counselling support from a clinical geneticist)
Huntington’s Australia provides genetic testing support resources

Middle Stage: Significant Daily Support Needs

The middle stage involves a substantial increase in support needs across motor, cognitive, and behavioural domains.

Provider handover considerations:

Issue	Action
Communication declining	Intensify speech pathology; consider AAC early before communication is severely impaired
Swallowing changes	Formal swallowing assessment; dietary modifications; train all support workers
Behaviour escalation	Formal behaviour support plan; medication review with neurologist/psychiatrist
Personal care needs increasing	Increase support worker hours; train workers in safe manual handling
Driving	Neurologist assesses fitness to drive; OT driving assessment; licence surrender process

Support worker training for middle stage:

Safe manual handling and transfer techniques
Safe mealtime positioning and recommended diet textures
Recognising and responding to behaviour that is neurologically driven
De-escalation strategies for irritability and aggression episodes
Communication strategies (allowing more time, using simple language, using visual supports)

Late Stage: Full-Time Care and Palliative Focus

The late stage of HD requires full-time care. Key considerations:

Living arrangement:

Many families manage late-stage HD at home with high-intensity support worker hours (including SIL where appropriate)
Some families transition to residential aged care or specialist accommodation in this stage
Specialist HD residential placements are rare in Australia; Huntington’s Australia can advise on options

Clinical priorities:

Swallowing management (aspiration risk is extreme; speech pathology review, PEG tube decision if not already made)
Pain assessment and management (HD causes pain that may not be communicated; palliative care involvement)
Respiratory management (aspiration pneumonia; respiratory physiotherapy for secretion clearance)
Skin integrity (risk of pressure injuries due to involuntary movement)
Comfort-focused positioning and care

Palliative care integration:

Palliative care physician engagement improves symptom management and reduces unnecessary interventions
Hospice support (in-home or inpatient) provides specialised end-of-life care
Bereavement support for family begins before death

The Provider Handover Checklist

When transitioning a person with HD between providers (a new support worker, a new speech pathologist, a transition from paediatric to adult services, or a transition to a new living arrangement), the handover checklist should include:

Medical and Clinical Information

Neurologist name and contact; medication list and current doses; most recent neurologist clinic letter
Speech pathology report (current diet texture and fluid consistency, swallowing assessment date, communication status)
Physiotherapy report (mobility aids, manual handling requirements, falls risk)
OT report (home setup, equipment in use, daily routine)
Behaviour support plan (current version; any restrictive practices and authorisations)
Advance care directive and EPA documentation (location and copies)

Daily Living Information

Daily routine (times, sequence of care, preferences)
Personal care requirements (showering, dressing, grooming; what assistance is needed and how)
Mealtime: diet texture, fluid consistency, positioning, monitoring requirements, what to do if choking occurs
Communication: current communication methods, effective strategies, what does NOT work
Behaviour: current behaviour profile, triggers, strategies, what to avoid

Emergency Information

Emergency contacts (primary family contact, neurologist, GP)
Emergency plan (what to do if the person falls, chokes, has a significant behaviour incident)
Do Not Resuscitate or advance care directive status (if applicable and relevant to the role)

Key Resources

Huntington’s Australia - helpline staffed by specialist advisors, peer support, information, and NDIS navigation
AIHW Huntington’s Disease Data - Australian epidemiology and prevalence data
Palliative Care Australia - information on accessing palliative care for progressive neurological conditions
NDIS Neurodegenerative, Palliative Care and Rare Diseases Advisory Group - NDIS reform for neurodegenerative conditions

Connecting with HD Support Providers

Carevo connects families with Huntington’s disease to speech pathologists, OTs, behaviour support practitioners, and NDIS-registered daily support providers across Australia.

Find a Huntington’s disease support provider through Carevo